Quality key factors
Factor
Value
Sales Growth (5y)
3.85%
EBIT Growth (5y)
-22.66%
EBIT to Interest (avg)
-2.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.01
Tax Ratio
2.93%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-0.36
EV to EBITDA
-0.57
EV to Capital Employed
0.18
EV to Sales
0.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-48.69%
ROE (Latest)
-43.50%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for TheraVet SA
Net Profit
Higher at EUR -0.85 MM
than preceding 12 month period ended Jun 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (EUR MM)
Operating Profit
Highest at EUR -0.63 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (EUR MM)
Debtors Turnover Ratio
Highest at 0.38%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio






